Water Immersion in Right-Sided Heart Failure: A Pilot Study
NCT ID: NCT00654264
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
13 participants
INTERVENTIONAL
2007-12-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Water Immersion in Chronic Stable Heart Failure
NCT02949544
Optimization of the Treatment of Acute HF by a Non Invasive Cardiac System-a Randomized Control Trial
NCT02126254
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure
NCT05240651
Spinal Cord Stimulation in Hypotensive Heart Failure Patients: Hemodynamic Assessment
NCT05288387
Feasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure Centers
NCT01654926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients will have water immersion on first day and sitting in a tub without water on the second day.
Water immersion
Subjects will sit in tub for four hours.
2
Patients will sit in a tub without water on the first day and have water immersion on the second day.
Water immersion
Subjects will sit in tub for four hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Water immersion
Subjects will sit in tub for four hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age greater than 18 years of age
* Right heart catheterization within the last year to rule out left-sided failure.
* Evidence of fluid overload as indicated by 2 or more of the following: 1.) 2+ or more pitting edema of the lower extremities, 2.) scrotal or penile edema, 3.) JVP greater than or equal to 10 cm, 4.) abdominal ascites
Exclusion Criteria
* Serum creatinine \> 2.0
* Current use of an angiotensin I converting enzyme inhibitor or angiotensin receptor blocker will preclude participation in the RAS neurohormone portion of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen Gottlieb
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Gottlieb, MD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-29283
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.